248 related articles for article (PubMed ID: 26773144)
1. Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes.
Radichev IA; Maneva-Radicheva LV; Amatya C; Salehi M; Parker C; Ellefson J; Burn P; Savinov AY
J Immunol; 2016 Feb; 196(4):1495-506. PubMed ID: 26773144
[TBL] [Abstract][Full Text] [Related]
2. Nardilysin-dependent proteolysis of cell-associated VTCN1 (B7-H4) marks type 1 diabetes development.
Radichev IA; Maneva-Radicheva LV; Amatya C; Parker C; Ellefson J; Wasserfall C; Atkinson M; Burn P; Savinov AY
Diabetes; 2014 Oct; 63(10):3470-82. PubMed ID: 24848066
[TBL] [Abstract][Full Text] [Related]
3. Altered Levels of Negative Costimulatory Molecule V-Set Domain-Containing T-Cell Activation Inhibitor-1 (VTCN1) and Metalloprotease Nardilysin (NRD1) are Associated with Generalized Active Vitiligo.
Vaishnav J; Jadeja SD; Singh M; Khan F; Yadav M; Begum R
Immunol Invest; 2022 Oct; 51(7):2035-2052. PubMed ID: 35815687
[TBL] [Abstract][Full Text] [Related]
4. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.
Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL
Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902
[TBL] [Abstract][Full Text] [Related]
5. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice.
Kornete M; Beauchemin H; Polychronakos C; Piccirillo CA
Autoimmunity; 2013 Jun; 46(4):259-68. PubMed ID: 23256897
[TBL] [Abstract][Full Text] [Related]
7. Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines.
Sun SQ; Jiang CG; Lin Y; Jin YL; Huang PL
J Int Med Res; 2012; 40(2):497-506. PubMed ID: 22613410
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells.
Pane JA; Webster NL; Zufferey C; Coulson BS
Virus Res; 2014 Jan; 179():73-84. PubMed ID: 24246305
[TBL] [Abstract][Full Text] [Related]
10. V-set domain containing T-cell activation inhibitor-1 (VTCN1): A potential target for the treatment of autoimmune diseases.
Vaishnav J; Khan F; Yadav M; Parmar N; Buch H; Jadeja SD; Dwivedi M; Begum R
Immunobiology; 2022 Nov; 227(6):152274. PubMed ID: 36095871
[TBL] [Abstract][Full Text] [Related]
11. B7-H4 expression in normal and diseased human islet β cells.
Cheung SS; Ou D; Metzger DL; Meloche M; Ao Z; Ng SS; Owen D; Warnock GL
Pancreas; 2014 Jan; 43(1):128-34. PubMed ID: 24326367
[TBL] [Abstract][Full Text] [Related]
12. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
Millet I; Wong FS; Gurr W; Wen L; Zawalich W; Green EA; Flavell RA; Sherwin RS
J Autoimmun; 2006 Feb; 26(1):7-15. PubMed ID: 16338119
[TBL] [Abstract][Full Text] [Related]
13. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
14. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
[TBL] [Abstract][Full Text] [Related]
15. Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes.
Pechhold K; Zhu X; Harrison VS; Lee J; Chakrabarty S; Koczwara K; Gavrilova O; Harlan DM
Diabetes; 2009 May; 58(5):1175-84. PubMed ID: 19228810
[TBL] [Abstract][Full Text] [Related]
16. Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.
Dai YD; Marrero IG; Gros P; Zaghouani H; Wicker LS; Sercarz EE
Diabetes; 2009 Jan; 58(1):156-64. PubMed ID: 18984740
[TBL] [Abstract][Full Text] [Related]
17. The central role of antigen presentation in islets of Langerhans in autoimmune diabetes.
Calderon B; Carrero JA; Unanue ER
Curr Opin Immunol; 2014 Feb; 26():32-40. PubMed ID: 24556398
[TBL] [Abstract][Full Text] [Related]
18. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
20. IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2.
Chakrabarti D; Hultgren B; Stewart TA
J Immunol; 1996 Jul; 157(2):522-8. PubMed ID: 8752897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
